Stéphane Bancel, Moderna CEO (Photo by Michael Brochstein/Sipa USA)(Sipa via AP Images)
Moderna reports slow start to RSV sales as Bancel steps back from commercial role
Moderna revealed the consequences of its late start in the market for RSV vaccines, reporting just $10 million in third-quarter sales from the new shot …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
